Human intestinal mucosa-associated Lactobacillus and Bifidobacterium strains with probiotic properties modulate IL-10, IL-6 and IL-12 gene expression in THP-1 cells

Benef Microbes. 2015;6(3):325-36. doi: 10.3920/BM2014.0081.

Abstract

Lactobacilli and bifidobacteria are considered one of the permanent genera of the physiological human intestinal microbiota and represent an enormous pool of potential probiotic candidates. Approximately 450 isolates of presumptive Lactobacillus or Bifidobacterium strains were obtained from bioptic samples of colonic and ileal mucosa from 15 adolescents aged 12 to 18 years. On the basis of randomly amplified polymorphic DNA (RAPD)-PCR analysis, 20 strains were selected for further taxonomic classification and characterisation, as well as assessment of probiotic properties and safety. Importantly, selected strains showed the capability of colonising different parts of the intestine. The most frequently isolated species was Lactobacillus paracasei followed by Lactobacillus fermentum. The majority of isolates were susceptible to antimicrobials of human and veterinary importance, however, tetracycline and/or erythromycin resistance was observed in Lactobacillus plantarum and L. fermentum strains. Thirteen strains were able to ferment more than 19 different carbon sources and three out of five tested strains exerted antagonistic activity against several different indicator strains. Two Lactobacillus isolates (L. paracasei L350 and L. fermentum L930 bb) and one Bifidobacterium isolate (Bifidobacterium animalis subsp. animalis IM386) fulfilled in vitro selection criteria for probiotic strains and exhibited strong downregulation of pro-inflammatory cytokines IL-6 and IL-12 and upregulation of anti-inflammatory IL-10. The selected strains represent suitable candidates for further studies regarding their positive influence on host health and could play an important role in ameliorating the symptoms of inflammatory bowel diseases.

Keywords: Lactobacillus, Bifidobacterium; intestinal microbiota; probiotic; safety assessment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Bifidobacterium / genetics
  • Bifidobacterium / isolation & purification
  • Bifidobacterium / physiology*
  • Child
  • Female
  • Gastrointestinal Diseases / microbiology
  • Humans
  • Interleukin-10 / genetics*
  • Interleukin-10 / immunology
  • Interleukin-12 / genetics*
  • Interleukin-12 / immunology
  • Interleukin-6 / genetics*
  • Interleukin-6 / immunology
  • Intestinal Mucosa / immunology
  • Intestinal Mucosa / microbiology*
  • Lactobacillus / genetics
  • Lactobacillus / isolation & purification
  • Lactobacillus / physiology*
  • Male
  • Monocytes / drug effects
  • Monocytes / immunology*
  • Probiotics / pharmacology*

Substances

  • IL10 protein, human
  • Interleukin-6
  • Interleukin-10
  • Interleukin-12